Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease.
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease. Am J Cardiol. 1996 Aug 15; 78(4):409-14.
View in:
PubMed
subject areas
Anticholesteremic Agents
Arteriosclerosis
Carotid Artery Diseases
Chemoprevention
Cholesterol, LDL
Coronary Artery Disease
Coronary Disease
Cost-Benefit Analysis
Costs and Cost Analysis
Decision Support Techniques
Hospitalization
Humans
Life Expectancy
Life Tables
Male
Markov Chains
Middle Aged
Myocardial Infarction
Placebos
Pravastatin
Risk Factors
Treatment Outcome
Value of Life